tirzepatide egfr cut off for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Adjusted analysis for the effect

Secondary outcomes included changes in eGFR, body weight, waist circumference, blood pressure, and high-sensitivity C-reactive protein (hsCRP)

How Tirzepatide Works in Your Body Tirzepatides unique dual-action mechanism enhances insulin secretion and reduces appetite

Ozempics ability to increase insulin secretion from the pancreas in turn reduces glucagon production, helping to maintain blood sugar homeostasis

These questions ensure that patients receive personalised care and support throughout their treatment journey

Participants receiving tirzepatide also had higher rates of reversion to normal blood sugar levels, with 89.9% of those on the 5-mg dose achieving normal blood sugar levels at week 176, compared to 58.9% of placebo participants

Reference: PubMed (2022)